Skip to content
Vulnerability Intelligence

CVE-2017-6527

HighPublic exploit

dnaLIMS is vulnerable to a NUL-terminated directory traversal attack allowing an unauthenticated attacker to access system files readable by the web server user (by using the viewAppletFsa.cgi seqID parameter).

Published Mar 9, 2017 · Updated May 12, 2026

Key Facts

Patch immediately
  • CVE-2017-6527 is a high-severity vulnerability (CVSS 7.5 v3) affecting Dnalims (Dnatools).
  • It is not listed in any known-exploited vulnerabilities catalog. Public exploit code is available.
  • EPSS estimates a 57% probability of exploitation in the next 30 days.
  • No fixed version is listed yet; check the vendor advisory for mitigations.
  • Brandefense priority: patch immediately, because it is very likely to be exploited soon.

CVSS v3

7.5

CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

EPSS (30-day exploit likelihood)

57%

Higher than 99.0% of all scored CVEs

Exploited in the wild

No known

Not in a known-exploited catalog

Public exploit code

Available

Proof-of-concept or weaponized module

Get the full CVE-2017-6527 brief as a PDF

Every affected product and fixed release, exploitation status and a first 24 hours response checklist, emailed within minutes.

Description

An issue was discovered in dnaTools dnaLIMS 4-2015s13. dnaLIMS is vulnerable to a NUL-terminated directory traversal attack allowing an unauthenticated attacker to access system files readable by the web server user (by using the viewAppletFsa.cgi seqID parameter).

Affected Products

1 affected entries in total
ProductAffected versionsFixed in
DnalimsDnatools4-2015s13n/a

Timeline

  1. Publicly disclosed

    Mar 9, 2017

  2. Last updated

    May 12, 2026

Weakness Type

  • CWE-22 Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')

References

FAQ

Common Questions.

Is CVE-2017-6527 Running On Your Attack Surface?

Brandefense maps vulnerabilities like this one to your internet-facing assets and tells you exactly where to patch.

Request A Demo